Nf1 haploinsufficient mice exhibit alterations in metabolism, including reduced fat mass, increased glucose clearance and insulin sensitivity, and reduced susceptibility to diet-induced obesity and hyperglycemia12. The gene discussed is INS; the disease is obesity disorder.